News

Tobramycin injection is an antibiotic and is indicated for the use in treating or preventing infections that are proven or strongly suspected to be caused by susceptible bacteria.

The US Patent Office has issued notices of intent to Issue Ex Parte Reexamination Certificates for US patents which claim preparations of, respectively, primate and human embryonic stem

Third Wave’s 14-type high-risk human papillomavirus (HPV) test demonstrated a negative predictive value greater than the study’s 99% goal. Negative predictive value is the probability that there is

After reviewing data on the safety and efficacy of the medication, the committee unanimously recommended approval of the company’s application for marketing. The FDA is not bound by

In particular the deal will directly enhance product development work for Clostridium difficile, E.coli and immune deficiency related opportunistic infections. The licensed technologies are all related to the

As part of the investigational new drug application (IND) submission, Arisaph has completed comprehensive nonclinical safety pharmacology and toxicology studies, including 28 day toxicology studies in rats and

The contract is for a period of five years with anticipated revenues of approximately $95 million. Under this agreement, Cognizant will provide a broad spectrum of centralized data

The purchase price will be approximately $117 million in cash. The current equity holders of BioArray intend to form a new company prior to closing, to commercialize BioArray

The study was conducted on 15,730 of the 16,608 postmenopausal women with an intact uterus who had participated in the Womenss Health Initiative (WHI) trial. The average age